Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease

Comment

D J Lanska. Neurology. 2001.

. 2001 May 22;56(10):1422-3.

doi: 10.1212/wnl.56.10.1422.

No abstract available

Comment on

Diagnosis of thymoma in myasthenics using anti-striated muscle antibodies: predictive value and gain in diagnostic certainty.
Lanska DJ. Lanska DJ. Neurology. 1991 Apr;41(4):520-4. doi: 10.1212/wnl.41.4.520. Neurology. 1991. PMID: 2011250
Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates.
Brandel JP, Delasnerie-Lauprêtre N, Laplanche JL, Hauw JJ, Alpérovitch A. Brandel JP, et al. Neurology. 2000 Mar 14;54(5):1095-9. doi: 10.1212/wnl.54.5.1095. Neurology. 2000. PMID: 10720280
Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.
Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S. Zerr I, et al. Neurology. 2000 Sep 26;55(6):811-5. doi: 10.1212/wnl.55.6.811. Neurology. 2000. PMID: 10994001